Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results
Go back to Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results| (NASDAQ: CRVS) | Delayed: 13.44 +1.02 (8.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.42 | 52 Week High | $17.77 | |||
| Open | $12.55 | 52 Week Low | $9.63 | |||
| Day High | $13.46 | P/E | N/A | |||
| Day Low | $12.35 | EPS | $0.00 | |||
| Volume | 806,628 | |||||

